nach oben

International Journal of Clinical Oncology

Erschienen in:

01.04.2019 | Original Article

Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population

verfasst von: Rong Wang, Hai-Mei Qin, Li Qin, Jing-Xi Wei, Yu-Xia Wei, Jun-Li Wang

Erschienen in: International Journal of Clinical Oncology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Emerging evidences were accumulated to support the view that GRP78 might be associated with multiple types of cancer. Given these, the aim of this study is to investigate the relationship between single nucleotide polymorphisms (SNPs) of GRP78 gene promoter and nasopharyngeal carcinoma (NPC).

Methods

Three SNPs (rs3216733, rs17840761 and rs17840762) in GRR78 promoter were estimated in 422 NPC patients and 452 controls. Genotyping was performed using SNaPshot SNP. Serum GRP78 level was performed by enzyme-linked immunosorbent assay (ELISA). Data were analyzed by SPSS 17.0 software.

Results

Significant association between rs3216733 polymorphism and NPC was observed (Cd vs. dd: OR = 0.57, 95% CI 0.43–0.76, P < 0.001; CC vs. dd: OR = 0.62, 95% CI 0.39–0.98, P = 0.043; Cd/CC vs. dd: OR = 0.58, 95% CI 0.44–0.76, P < 0.001; C vs. d OR = 0.70, 95% CI 0.57–0.86, P = 0.001). Additionally, we further found that expression were down-regulated in serum of patients with NPC carrying rs3216733 CC genotype when compared to that of dd genotype (P < 0.001).

Conclusion

The observations suggest that rs3216733 polymorphism in the GRP78 gene promoter may correlate with NPC susceptibility.

Chang ET, Liu Z, Hildesheim A, et al (2017) Active and passive smoking and risk of nasopharyngeal carcinoma: a population-based case-control study in Southern China. Am J Epidemiol 185(12):1272–1280. https://doi.org/10.1093/aje/kwx018 CrossRefPubMedPubMedCentral

Kang M, Zhou P, Wei T, et al (2017) A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study. Am J Cancer Res 7(2):346–356PubMedPubMedCentral

Stoker SD, Novalic Z, Wildeman MA, et al (2015) Epstein–Barr virus-targeted therapy in nasopharyngeal carcinoma. J Cancer Res Clin Oncol 141(10):1845–1857. https://doi.org/10.1007/s00432-015-1969-3 CrossRefPubMed

Roy Chattopadhyay N, Das P, Chatterjee K, et al (2017) Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli. Drug Discov Ther 11(4):170–180. https://doi.org/10.5582/ddt.2017.01030 CrossRefPubMed

Yong SK, Ha TC, Yeo MC, et al (2017) Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: a case-control study. Chin J Cancer 36(1):3. https://doi.org/10.1186/s40880-016-0174-3 CrossRefPubMedPubMedCentral

Cao L, Li P, Dong L (2017) Matrix metalloproteinase-1 (MMP-1) rs1799750 polymorphism is associated with nasopharyngeal carcinoma (NPC) risk. Cell Mol Biol (Noisy-le-Grand. France) 63(10):1–3. https://doi.org/10.14715/cmb/2017.63.10.1 CrossRef

Lu Z, Li S, Ning S, et al (2018) Association of the rs1760944 polymorphism in the APEX1 base excision repair gene with risk of nasopharyngeal carcinoma in a population from an endemic area in South China. J Clin Lab Anal 32 (2):e22238. https://doi.org/10.1002/jcla.22238 CrossRef

Tan J, Jiang L, Cheng X, et al (2017) Association between VEGF-460T/C gene polymorphism and clinical outcomes of nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. OncoTargets Therapy 10:909–918. https://doi.org/10.2147/ott.s126159 CrossRefPubMed

Hui EP, Ma BB, Chan KC, et al (2015) Clinical utility of plasma Epstein–Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma. Cancer 121(16):2720–2729. https://doi.org/10.1002/cncr.29413 CrossRefPubMed

10.

Chin YM, Mushiroda T, Takahashi A, et al (2015) HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. Int J Cancer 136(3):678–687. https://doi.org/10.1002/ijc.29035 CrossRefPubMed

11.

Lei J, Zhao L, Zhang Y, et al (2018) High Glucose-induced podocyte injury involves activation of mammalian target of rapamycin (mTOR)-induced endoplasmic reticulum (ER) stress. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 45 (6):2431–2443. https://doi.org/10.1159/000488231 CrossRef

12.

Huang YY, Pu LJ, Song LL, et al (2016) Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells. Anti Cancer Drugs 27(8):726–733. https://doi.org/10.1097/cad.0000000000000377 CrossRefPubMed

13.

Fu WM, Lu YF, Hu BG, et al (2016) Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways. Oncotarget 7(4):4712–4723. https://doi.org/10.18632/oncotarget.6731 CrossRefPubMed

14.

Endo S, Hiramatsu N, Hayakawa K, et al (2007) Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSP70), elicits unfolded protein response and coordinates cellular fate independently of HSP70. Mol Pharmacol 72(5):1337–1348. https://doi.org/10.1124/mol.107.039164 CrossRefPubMed

15.

Zhu X, Zhang J, Fan W, et al (2013) The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma. Carcinogenesis 34(6):1273–1280. https://doi.org/10.1093/carcin/bgt061 CrossRefPubMed

16.

Merrick DT (2012) GRP78, intronic polymorphisms, and pharmacogenomics in non-small cell lung cancer. Chest 141(6):1377–1378. https://doi.org/10.1378/chest.11-2662 CrossRefPubMed

17.

Poyyakkara A, Raji GR, Kunhiraman H, et al (2018) ER stress mediated regulation of miR23a confer Hela cells better adaptability to utilize glycolytic pathway. J Cell Biochem https://doi.org/10.1002/jcb.26718 CrossRefPubMed

18.

Rodvold JJ, Kesari S, Zanetti M (2017) A community affair in the tumor microenvironment. Oncotarget 8(63):106173–106174. https://doi.org/10.18632/oncotarget.22586 CrossRefPubMedPubMedCentral

19.

Griesemer M, Young C, Robinson AS, et al (2014) BiP clustering facilitates protein folding in the endoplasmic reticulum. PLoS Comput Biol 10(7):e1003675. https://doi.org/10.1371/journal.pcbi.1003675 CrossRefPubMedPubMedCentral

20.

Behnke J, Mann MJ, Scruggs FL, et al (2016) Members of the Hsp70 family recognize distinct types of sequences to execute ER quality control. Mol cell 63(5):739–752. https://doi.org/10.1016/j.molcel.2016.07.012 CrossRefPubMedPubMedCentral

21.

Wang M, Ye R, Barron E, et al (2010) Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis. Cell Death Diff 17(3):488–498. https://doi.org/10.1038/cdd.2009.144 CrossRef

22.

Liu KC, Lin YJ, Hsiao YT, et al (2017) Tetrandrine induces apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells by endoplasmic reticulum stress and Ca(2+)/calpain pathways. Anticancer Res 37(11):6107–6118. https://doi.org/10.21873/anticanres.12059 CrossRefPubMed

23.

Lin YJ, Peng SF, Lin ML, et al (2016) Tetrandrine induces apoptosis of human nasopharyngeal carcinoma NPC-TW 076 cells through reactive oxygen species accompanied by an endoplasmic reticulum stress signaling pathway. Molecules 21 (10):1353. https://doi.org/10.3390/molecules21101353 CrossRefPubMedCentral

24.

Li C, Zhang B, Lv W, et al (2016) Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells. Oncotarget 7(31):49588–49596. https://doi.org/10.18632/oncotarget.10412 CrossRefPubMedPubMedCentral

25.

Kakiuchi C, Ishiwata M, Nanko S, et al (2005) Functional polymorphisms of HSPA5: possible association with bipolar disorder. Biochem Biophys Res Commun 336(4):1136–1143. https://doi.org/10.1016/j.bbrc.2005.08.248 CrossRefPubMed

26.

Yoshida H, Haze K, Yanagi H, et al (1998) Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 273(50):33741–33749CrossRef

27.

Li WW, Hsiung Y, Zhou Y, et al (1997) Induction of the mammalian GRP78/BiP gene by Ca2 + depletion and formation of aberrant proteins: activation of the conserved stress-inducible grp core promoter element by the human nuclear factor YY1. Mol Cell Biol 17(1):54–60CrossRefPubMedPubMedCentral

28.

Hsu WC, Wang HK, Lee LC, et al (2008) Promoter polymorphisms modulating HSPA5 expression may increase susceptibility to Taiwanese Alzheimer’s disease. J Neural Trans (Vienna, Austria: 1996) 115(11):1537–1543. https://doi.org/10.1007/s00702-008-0117-5 CrossRef

29.

Zhu X, Li DP, Fan WG, et al (2010) Lack of association between the GRP78 polymorphisms in the promoter and 3′ UTR and susceptibility to chronic HBV infection in a Chinese Han population. BMC Med Genet 11:83. https://doi.org/10.1186/1471-2350-11-83 CrossRefPubMedPubMedCentral

30.

Liu S, Li K, Li T, et al (2013) Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population. DNA Cell Biol 32(3):119–124. https://doi.org/10.1089/dna.2012.1909 CrossRefPubMedPubMedCentral

Titel: Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population
verfasst von: Rong Wang
Hai-Mei Qin
Li Qin
Jing-Xi Wei
Yu-Xia Wei
Jun-Li Wang
Publikationsdatum: 01.04.2019
Verlag: Springer Singapore
Erschienen in: International Journal of Clinical Oncology / Ausgabe 4/2019
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-018-1366-4

Springer Medizin

Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Histologic transformation of non-small-cell lung cancer in brain metastases

Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)

To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?

The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study

Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case–control studies

Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie